ES2586283T3 - Emulsiones autoconservadas - Google Patents

Emulsiones autoconservadas Download PDF

Info

Publication number
ES2586283T3
ES2586283T3 ES09767290.1T ES09767290T ES2586283T3 ES 2586283 T3 ES2586283 T3 ES 2586283T3 ES 09767290 T ES09767290 T ES 09767290T ES 2586283 T3 ES2586283 T3 ES 2586283T3
Authority
ES
Spain
Prior art keywords
formula
alkyl
alkenyl
equal
self
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09767290.1T
Other languages
English (en)
Inventor
Masood A. Chowhan
Malay Ghosh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of ES2586283T3 publication Critical patent/ES2586283T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Una emulsión adecuada para administración ocular, nasal u ótica que comprende agua, un agente de regulación, un aceite, un emulsificador, un ajustador de pH, un compuesto sintético multifuncional de la fórmula I, **Fórmula** en donde: x es 1 a 3 o mezclas de los mismos; x+y es igual a 3; a es 0 a 2; z es igual a x; B es O- u OM; A es un anión; M es un catión; Y se selecciona del grupo que consiste de OH, O-alquilo C1-C10 y O-alquenilo C1-C10; y R1, R2 y R3 son los mismos o diferentes y son alquilo, alquilo sustituido, grupos alquilo arilo o alquenilo, opcionalmente interrumpidos por -NHC(>=O)-, de hasta 16 átomos de carbono con la condición de que los átomos de carbono totales en R1+R2+R3 está entre 10 y 24, y opcionalmente un agente terapéutico, en donde la cantidad de el compuesto de la fórmula I es desde 0.05 hasta 0.2%.

Description

d -aa  ddliaaad tieo--mromndTíooMmC T dF33An.//2M13NC T tsF73A1M.//13NC . r oau nl03uF./ g00aneirNÁ a.. r n n o03uea.tu/gí00nDlnIFi Nnu e d eaaad ce n i03uanp./ger00óónrTci ÁNralu d caaOaed n inr03udsó./ogac00bd niueidNNdom o C a s nyi03u t./nigr00Inóii cNBat5ir Ar I aoLem nBd03uA en./gTtói00rniicENaula v e Eod neo z03udju./ egBll00fni enNRóicalu m. jn alroaomC tF--i on.íiTrrMI . .j sn03Aeo.//0ND0C- a . m. njn03Aaóo.//il00fcNCnI ..gjn n o33AoC.//C01N ADIACDNI EARIDEDIVECEMN IS
ES09767290.1T 2008-05-28 2009-05-27 Emulsiones autoconservadas Active ES2586283T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5667508P 2008-05-28 2008-05-28
US56675P 2008-05-28
PCT/US2009/045282 WO2009154978A2 (en) 2008-05-28 2009-05-27 Self-preserved emulsions

Publications (1)

Publication Number Publication Date
ES2586283T3 true ES2586283T3 (es) 2016-10-13

Family

ID=41203940

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09767290.1T Active ES2586283T3 (es) 2008-05-28 2009-05-27 Emulsiones autoconservadas

Country Status (9)

Country Link
US (1) US20090298956A1 (es)
EP (1) EP2278953B1 (es)
JP (1) JP2011521957A (es)
KR (2) KR20110010788A (es)
AU (1) AU2009260572B2 (es)
BR (1) BRPI0912302A2 (es)
CA (1) CA2725523C (es)
ES (1) ES2586283T3 (es)
WO (1) WO2009154978A2 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE412400T1 (de) * 2004-11-09 2008-11-15 Novagali Pharma Sa Öl-in-wasser-emulsion mit niedriger konzentration des kationischen mittels und positivem zetapotential
EP2228058A1 (en) 2009-03-04 2010-09-15 Novagali Pharma S.A. Anionic oil-in-water emulsion containing prostaglandins and uses thereof
EP2389939A1 (en) 2010-05-28 2011-11-30 Novagali Pharma S.A. Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
JP5673278B2 (ja) * 2011-03-24 2015-02-18 日油株式会社 ホスホリルコリン類似構造を有する化合物および化粧料
JP5782846B2 (ja) * 2011-06-13 2015-09-24 日油株式会社 ホスホリルコリン類似構造を有する化合物および化粧料
JP5782847B2 (ja) * 2011-06-13 2015-09-24 日油株式会社 ホスホリルコリン類似構造を有する化合物および化粧料
EP2887923B1 (en) 2012-08-24 2023-04-05 Sun Pharmaceutical Industries Limited Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions
PT3373976T (pt) 2015-11-10 2024-04-02 Sun Pharmaceutical Ind Ltd Formulações tópicas e suas utilizações
WO2017151657A1 (en) 2016-02-29 2017-09-08 Ocular Technologies Sarl Topical cyclosporine-containing formulations and uses thereof
ITUA20162425A1 (it) * 2016-04-08 2017-10-08 Medivis S R L Composizione oftalmica che comprende PVP-I
CN108201526A (zh) * 2018-03-13 2018-06-26 云南云龙制药股份有限公司 一种治疗鼻炎的凝胶及其制备方法和应用
WO2021032073A1 (en) * 2019-08-18 2021-02-25 IVIEW Therapeutics (Zhuhai) Co., Ltd. In-situ gel containing cyclosporine micelles as sustained ophthalmic drug delivery system
AR124568A1 (es) * 2021-01-16 2023-04-12 Godrej Industries Ltd Agentes antifúngicos, mezcla de los mismos y composiciones de limpieza para el cuidado personal que los contienen
CN115463088A (zh) * 2021-06-11 2022-12-13 温士顿医药股份有限公司 含前列腺素衍生物的眼用纳米乳剂组合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608073A (en) * 1968-07-16 1971-09-21 Barnes Hind Pharm Inc Emulsion of pilocarpine for ophthalmic use
US4215064A (en) * 1978-11-30 1980-07-29 Johnson & Johnson Phosphobetaines
US4503002A (en) * 1978-11-30 1985-03-05 Mona Industries, Inc. Phosphate quaternary compounds
US4209449A (en) * 1978-11-30 1980-06-24 Mona Industries Phosphate quaternary compounds
US4407791A (en) * 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US5286719A (en) * 1991-10-28 1994-02-15 Mona Industries, Inc. Phospholipid virucidal compositions
MX9206219A (es) * 1991-10-28 1994-01-31 Mona Industries Inc Composiciones antimicrobianas de fosfolipidos
US5648348A (en) * 1991-10-28 1997-07-15 Mona Industries, Inc. Phospholipid antimicrobial compositions
US5505953A (en) * 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
EP0724622A1 (en) * 1993-07-01 1996-08-07 Allergan, Inc. Contact lens cleaning solution based on quaternary ammonium phosphate esters
JP2742333B2 (ja) * 1994-05-06 1998-04-22 アルコン ラボラトリーズ，インコーポレイテッド 眼科用組成物におけるビタミンｅトコフェリル誘導体の使用
ES2094688B1 (es) * 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US5827835A (en) * 1994-08-30 1998-10-27 Alcon Laboratories, Inc. Thermally-gelling emulsions
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
ES2207748T3 (es) * 1996-08-09 2004-06-01 Alcon Manufacturing Ltd. Sistemas conservantes para composiciones farmaceuticas que contienen ciclodextrinas.
EP1020194A4 (en) * 1997-10-01 2003-05-21 Wakamoto Pharma Co Ltd OIL / WATER EMULSION COMPILATIONS
US6120758A (en) * 1998-07-16 2000-09-19 Shaklee Corporation Preservative system for topically applied products
US6284749B1 (en) * 1998-10-27 2001-09-04 Alcon Manufacturing, Ltd. Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
US6750250B1 (en) * 2001-07-12 2004-06-15 Alcon, Inc. 11,12-oxidoarachidonic acid derivatives and methods of their use in treating dry eye disorders
US6451775B1 (en) * 2001-08-29 2002-09-17 Colonial Chemical Inc. Castor amidopropyl dimethyl phospholipids as emulsifiers
US6585961B1 (en) * 2001-11-30 2003-07-01 Richard F. Stockel Antimicrobial compositions
AU2003230890A1 (en) * 2002-04-11 2003-10-27 Dvm Pharmaceuticals, Inc. Antimicrobial wash and carrier solutions, and uses thereof
US20060141059A1 (en) * 2004-12-27 2006-06-29 Alcon, Inc. Self-preserved ophthalmic pharmaceutical compositions containing tobramycin
US20070297990A1 (en) * 2006-06-27 2007-12-27 Shah Mandar V Self-preserving composition
WO2008035246A2 (en) * 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions containing quaternary ammonium compounds
US20080026013A1 (en) * 2006-07-28 2008-01-31 Laura Rabinovich-Guilatt Compositions containing quaternary ammonium compounds
TW200904485A (en) * 2007-05-18 2009-02-01 Alcon Res Ltd Phospholipid compositions for contact lens care and preservation of pharmaceutical compositions

Also Published As

Publication number Publication date
CA2725523C (en) 2017-01-10
BRPI0912302A2 (pt) 2015-10-20
WO2009154978A3 (en) 2010-04-22
CA2725523A1 (en) 2009-12-23
AU2009260572B2 (en) 2015-07-23
JP2011521957A (ja) 2011-07-28
KR20110010788A (ko) 2011-02-07
EP2278953B1 (en) 2016-05-04
AU2009260572A1 (en) 2009-12-23
EP2278953A2 (en) 2011-02-02
WO2009154978A2 (en) 2009-12-23
KR20160123400A (ko) 2016-10-25
US20090298956A1 (en) 2009-12-03

Similar Documents

Publication Publication Date Title
ES2586283T3 (es) Emulsiones autoconservadas
GT200500242A (es) Procesos para la preparaciòn de 2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolinas sustituidas
ECSP088774A (es) Derivados de benzonitrilo sustituidos con glucopiranosilo, composiciones farmacéuticas que contienen compuestos de este tipo, su uso y procedimiento para su fabricación.
AR065134A1 (es) Compuestos triciclicos, composicion que los comprende y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por el receptor de glucocorticoides.
CY1118436T1 (el) Συνθεσεις που περιεχουν ενωσεις τεταρτοταγους αμμωνιου
PA8609201A1 (es) Piridinonas sustituidas
PE20221457A1 (es) Degradadores de moleculas pequenas de helios y procedimientos de uso
ECSP055536A (es) Derivados de 1-heterociclilalquil-3-sulfonilindol o indazol como ligandos de 5-hidroxitriptamina-6
ECSP056127A (es) Inhibidores de 3-quinasa de fosfatidil-inositol
PA8575401A1 (es) Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso
UY28683A1 (es) Fenilalanina- amidas sustituidas por benzilo-
ECSP055582A (es) Derivados de benzotiazol que tienen actividad agonista de beta-2-adrenorreceptor
CO5570667A2 (es) Compuestos azabiciclico sustituidos condensados con heteroarilo para el tratamiento de enfermedades
UY28852A1 (es) Nuevos compuestos con estructura de alquino con acción antagonista de mch y medicamentos que contienen estos compuestos
BRPI0413353A (pt) composição farmacêutica contendo droga solúvel em água
SV2008002828A (es) Agentes para prevenir y tratar trastornos que involucran la modulacion de los receptores ryr ref. 19240-619-sv1
CR8476A (es) Fenilalanina-amidas sustituidas por heteroaroilo
ECSP045253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
BRPI0411361A (pt) composições oftálmicas contendo uma combinação sinérgica de dois polìmeros
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
MD4626B1 (ro) Derivaţi de tamoxifen pentru tratamentul afecţiunilor neoplazice, în special cu nivel înalt de proteină HER2
ECSP21080096A (es) Composiciones y métodos para el tratamiento de enfermedades mediadas por kit y pdgfra
CL2022000093A1 (es) Imidazopirimidinas como inhibidores de eed y uso de estas
MX9307232A (es) Arilcicloalquilaminas n,n-disustituidas, sus sales, medicamentos que contiene estos compuestos y su empleo, asi como procedimientos para su preparacion.
AR073043A1 (es) Compuestos de azetidinas polisustituidos, composiciones farmaceuticas que los contienen, metodo de preparacion y uso de los mismos en el tratamiento de enfermedades respiratorias, metabolicas y del sistema nervioso central, entre otras.